𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen receptor (ER) variations in breast cancer during the course of disease

✍ Scribed by S. Toma; R. Paridaens; G. Leclerq; J.C. Heuson

Book ID
116003424
Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
114 KB
Volume
19
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Estrogen-induced interaction between KLF
Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells
✍ Peng Guo; Xue-Yuan Dong; Ke-Wen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 368 KB

## Abstract Kruppel‐like factor 5 (KLF5) is implicated in human breast cancer by frequent genomic deletion and expressional deregulation, but the molecular mechanisms by which KLF5 affects breast tumorigenesis are still unknown. This study was conducted to examine whether and how KLF5 affects the f

Analysis of the potential contribution o
Analysis of the potential contribution of estrogen receptor (ER) Ξ² in ER cytosolic assay of breast cancer
✍ J.P. Brouillet; M.A. Dujardin; D. Chalbos; J.M. Rey; J. Grenier; P.J. Lamy; T. M πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 2 views

Estrogen receptor (ER) content is the most useful parameter for predicting hormone response therapy in breast cancer. Assays available for detecting ER in breast tumor cytosol are ligand-binding assay (LBA), which detects both ER␣ and ER␀, and the enzymatic immunoassay (EIA), in which monoclonal ant